Tyrosine Kinase 2 Plays Critical Roles in the Pathogenic CD4 T Cell Responses for the Development of Experimental Autoimmune Encephalomyelitis-Reference-Cited by-同舟云学术

Tyrosine Kinase 2 Plays Critical Roles in the Pathogenic CD4 T Cell Responses for the Development of Experimental Autoimmune Encephalomyelitis

Published:2009-11-16 Issue:11 Volume:183 Page:7539-7546
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Oyamada Akiko,Ikebe Hiori,Itsumi Momoe,Saiwai Hirokazu,Okada Seiji,Shimoda Kazuya,Iwakura Yoichiro,Nakayama Keiichi I.,Iwamoto Yukihide,Yoshikai Yasunobu,Yamada Hisakata

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference41 articles.

1. The T Lymphocyte in Experimental Allergic Encephalomyelitis

2. IL-17 Plays an Important Role in the Development of Experimental Autoimmune Encephalomyelitis

3. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain

4. Novel p19 Protein Engages IL-12p40 to Form a Cytokine, IL-23, with Biological Activities Similar as Well as Distinct from IL-12

5. Compromised Humoral and Delayed-Type Hypersensitivity Responses in IL-23-Deficient Mice

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tyrosine kinase 2 modulates splenic B cells through type I IFN and TLR7 signaling;Cellular and Molecular Life Sciences;2024-04-29

2. TYK2 signaling promotes the development of autoreactive CD8+ cytotoxic T lymphocytes and type 1 diabetes;Nature Communications;2024-02-13

3. TARGETING SELECTIVE TYROSINE KINASE 2 (TYK2) INHIBITORS FOR THE TREATMENT OF AUTOIMMUNE DISEASES;Medicinal Chemistry Reviews;2023-11-16

4. A novel highly selective allosteric inhibitor of tyrosine kinase 2 (TYK2) can block inflammation- and autoimmune-related pathways;Cell Communication and Signaling;2023-10-16

5. Tyk2-mediated signaling promotes the development of autoreactive CD8⁺CTLs and autoimmune type 1 diabetes;2023-07-15